708 related articles for article (PubMed ID: 17360662)
21. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes.
Zhang D; Yang H; Kong X; Wang K; Mao X; Yan X; Wang Y; Liu S; Zhang X; Li J; Chen L; Wu J; Wei M; Yang J; Guan Y
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E287-95. PubMed ID: 20959534
[TBL] [Abstract][Full Text] [Related]
22. FOG2 protein down-regulation by transforming growth factor-β1-induced microRNA-200b/c leads to Akt kinase activation and glomerular mesangial hypertrophy related to diabetic nephropathy.
Park JT; Kato M; Yuan H; Castro N; Lanting L; Wang M; Natarajan R
J Biol Chem; 2013 Aug; 288(31):22469-80. PubMed ID: 23788640
[TBL] [Abstract][Full Text] [Related]
23. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
Akahori H; Ota T; Torita M; Ando H; Kaneko S; Takamura T
J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
[TBL] [Abstract][Full Text] [Related]
24. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
25. Connective tissue growth factor antagonizes transforming growth factor-β1/Smad signalling in renal mesangial cells.
O'Donovan HC; Hickey F; Brazil DP; Kavanagh DH; Oliver N; Martin F; Godson C; Crean J
Biochem J; 2012 Jan; 441(1):499-510. PubMed ID: 21871016
[TBL] [Abstract][Full Text] [Related]
26. Metformin inhibits extracellular matrix accumulation, inflammation and proliferation of mesangial cells in diabetic nephropathy by regulating H19/miR-143-3p/TGF-β1 axis.
Xu J; Xiang P; Liu L; Sun J; Ye S
J Pharm Pharmacol; 2020 Aug; 72(8):1101-1109. PubMed ID: 32391614
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor β1 antagonizes the transcription, expression and vascular signaling of guanylyl cyclase/natriuretic peptide receptor A - role of δEF1.
Sen A; Kumar P; Garg R; Lindsey SH; Katakam PV; Bloodworth M; Pandey KN
FEBS J; 2016 May; 283(9):1767-81. PubMed ID: 26934489
[TBL] [Abstract][Full Text] [Related]
28. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
29. MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells.
Park J; Ryu DR; Li JJ; Jung DS; Kwak SJ; Lee SH; Yoo TH; Han SH; Lee JE; Kim DK; Moon SJ; Kim K; Han DS; Kang SW
Am J Physiol Renal Physiol; 2008 Sep; 295(3):F749-57. PubMed ID: 18579703
[TBL] [Abstract][Full Text] [Related]
30. Cited2 modulates TGF-beta-mediated upregulation of MMP9.
Chou YT; Wang H; Chen Y; Danielpour D; Yang YC
Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation.
Zheng F; Fornoni A; Elliot SJ; Guan Y; Breyer MD; Striker LJ; Striker GE
Am J Physiol Renal Physiol; 2002 Apr; 282(4):F639-48. PubMed ID: 11880325
[TBL] [Abstract][Full Text] [Related]
32. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression.
Wang Y; Liu L; Peng W; Liu H; Liang L; Zhang X; Mao Y; Zhou X; Shi M; Xiao Y; Zhang F; Zhang Y; Liu L; Yan R; Guo B
J Cell Physiol; 2019 Aug; 234(10):17925-17936. PubMed ID: 30847937
[TBL] [Abstract][Full Text] [Related]
33. Abated microRNA-195 expression protected mesangial cells from apoptosis in early diabetic renal injury in mice.
Chen YQ; Wang XX; Yao XM; Zhang DL; Yang XF; Tian SF; Wang NS
J Nephrol; 2012; 25(4):566-76. PubMed ID: 21983986
[TBL] [Abstract][Full Text] [Related]
34. Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs.
Fiorentino L; Cavalera M; Mavilio M; Conserva F; Menghini R; Gesualdo L; Federici M
Acta Diabetol; 2013 Dec; 50(6):965-9. PubMed ID: 23797704
[TBL] [Abstract][Full Text] [Related]
35. Novel lncRNA Erbb4-IR Promotes Diabetic Kidney Injury in
Sun SF; Tang PMK; Feng M; Xiao J; Huang XR; Li P; Ma RCW; Lan HY
Diabetes; 2018 Apr; 67(4):731-744. PubMed ID: 29222368
[TBL] [Abstract][Full Text] [Related]
36. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.
McClelland AD; Herman-Edelstein M; Komers R; Jha JC; Winbanks CE; Hagiwara S; Gregorevic P; Kantharidis P; Cooper ME
Clin Sci (Lond); 2015 Dec; 129(12):1237-49. PubMed ID: 26415649
[TBL] [Abstract][Full Text] [Related]
37. CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGFβ type II receptor with implications for nephropathic cell phenotypes.
Faherty N; Curran SP; O'Donovan H; Martin F; Godson C; Brazil DP; Crean JK
J Cell Sci; 2012 Dec; 125(Pt 23):5621-9. PubMed ID: 22976296
[TBL] [Abstract][Full Text] [Related]
38. Effects of microRNA-370 on mesangial cell proliferation and extracellular matrix accumulation by binding to canopy 1 in a rat model of diabetic nephropathy.
Yu FN; Hu ML; Wang XF; Li XP; Zhang BH; Lu XQ; Wang RQ
J Cell Physiol; 2019 May; 234(5):6898-6907. PubMed ID: 30317577
[TBL] [Abstract][Full Text] [Related]
39. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Xu LP; Zhu ZY; Li JY; Zhou SN; Cui FQ; Zeng XJ; Geng JG; Yang JK
Am J Physiol Renal Physiol; 2014 Mar; 306(5):F486-95. PubMed ID: 24370587
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling in glomeruli of diabetic nephropathy rat.
Zhang Q; Xiao X; Li M; Li W; Yu M; Zhang H; Sun X; Mao L; Xiang H
Exp Biol Med (Maywood); 2012 Aug; 237(8):903-11. PubMed ID: 22903132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]